Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have improved survival following immunotherapy compared to patients without ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

Researchers have traced where and when the HIV protective mutation arose but also how it gave northern European ancestors a competitive advantage against ancient diseasesA genetic mutation in a ...

Those with the genetic mutation have what is called a “32-bp deletion,” which means the gene known as chemokine receptor 5, or CCR5, isn’t fully expressed, according to the study.

Those with the genetic mutation have what is called a “32-bp deletion,” which means the gene known as chemokine receptor 5, or CCR5, isn’t fully expressed, according to the study.

Those with the genetic mutation have what is called a “32-bp deletion,” which means the gene known as chemokine receptor 5, or CCR5, isn’t fully expressed, according to the study.